SCHEMBL7184655

SCHEMBL7184655

CCCCC([O])c1ccc(OC)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
PDE4D Q08499 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
ACHE P22303 2/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
LMNA P02545 2/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC2 Q92769 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TNF P01375 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187157 0.95 PPARG (0.45) PPARGPPARDPPARAPDE4DSMN1; SMN2
SCHEMBL7179479 0.89 PPARG (0.49) PPARGPPARDPPARAPDE4DACHE
SCHEMBL7182938 0.83 PPARG (0.53) PPARGPPARDPPARAACHECA1
SCHEMBL9588933 0.83 SMN1; SMN2 (0.45) PPARGPPARDPPARAPDE4DSMN1; SMN2
SCHEMBL6055199 0.83 PDE4D (0.62) PPARGPPARDPPARAPDE4DSMN1; SMN2
SCHEMBL26394256 0.81 PDE4D (0.45) PPARGPPARDPPARAPDE4DSMN1; SMN2
SCHEMBL22210842 0.81 PDE4D (0.45) PPARGPPARDPPARAPDE4DSMN1; SMN2
SCHEMBL4862475 0.81 ACHE (0.45) PPARGPPARDPPARAPDE4DSMN1; SMN2
SCHEMBL5158784 0.80 ACHE (0.51) PPARGPPARDPPARAPDE4DSMN1; SMN2
SCHEMBL11291735 0.79 PDE4D (0.59) PDE4DKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6582351-B1 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-24 US disclosed
EP-1196391-A1 BENZIMIDAZOLONE DERIVATIVES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-17 EP disclosed
WO-2001005770-A1 BENZIMIDAZOLONE DERIVATIVES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-25 WO disclosed
US-4683234-A HYPOTENSIVE AGENTS, ANTI-ANGINA SUNTORY LIMITED (JP) 1987-07-28 US disclosed
EP-0162208-A2 Novel N-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) 1985-11-27 EP disclosed